Currently, 16 loci that contribute to the development of IDDM in the NOD mouse have been mapped by linkage analysis. To fine map these loci, we used congenic mapping. Using this approach, we localized the Idd3 locus to a 0.35-cM interval on chromosome 3 containing the Il2 gene. Segregation analysis of the known variations within this interval indicated that only one variant, a serine-to-proline substitution at position 6 of the mature interleukin-2 (IL-2) protein, consistently segregates with IDDM in crosses between NOD and a series of nondiabetic mouse strains. These data, taken together with the immunomodulatory role of IL-2, provide circumstantial evidence in support of the hypothesis that Idd3 is an allelic variation of the Il2 gene, or a variant in strong linkage disequilibrium.
Mapping of the IDDM Locus Idd3 to a 0.35-cM Interval Containing the Interleukin-2 Gene
AOD, autoimmune ovarian dysgenesis; FISH, fluorescent in situ hybridization; FITC, fluorescein isothiocyanate; IBD, identical by descent; IL-2, interleukin-2; IL2 gene, Interleukin-2 human gene; 112 gene, Interleukin-2 rodent gene; IRE, interspersed repetitive element; NOD, nonobese diabetic; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; SSLP, simple sequence length polymorphism; STS, sequencetagged site; YAC, yeast artificial chromosome.
Paul Denny, Christopher J Lord, Natasha J Hill, Juliet V Goy, Elaine R Levy, Patricia L Podolin, Laurence B Peterson, Linda S Wicker, John A Todd, Paul A Lyons; Mapping of the IDDM Locus Idd3 to a 0.35-cM Interval Containing the Interleukin-2 Gene. Diabetes 1 April 1997; 46 (4): 695–700. https://doi.org/10.2337/diab.46.4.695
Download citation file: